NPY1R, a novel peripheral blood marker, is upregulated in breast cancer, promoting proliferation and migration, and is positively correlated with metastatic diseases and highly expressed in circulating tumor cells among breast cancer patients [60,61] . Here, NPY1R is linked to metastatic neoplasm.